| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Altimmune Inc (NASDAQ: ALT)
ALT Technical Analysis
5
| As on 9th Jun 2023 ALT STOCK Price closed @ 4.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 9.72 & Strong Sell for SHORT-TERM with Stoploss of 7.92 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ALTSTOCK Price
| Open | 4.10 | Change | Price | % |
| High | 4.10 | 1 Day | -0.09 | -2.20 |
| Low | 3.97 | 1 Week | -0.09 | -2.20 |
| Close | 4.00 | 1 Month | -1.23 | -23.52 |
| Volume | 1218520 | 1 Year | -5.36 | -57.26 |
| 52 Week High 22.41 | 52 Week Low 3.87 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ALT Daily Charts |
ALT Intraday Charts |
Whats New @ Bazaartrend |
ALT Free Analysis |
|
|
ALT Important Levels Intraday
| RESISTANCE | 4.25 |
| RESISTANCE | 4.17 |
| RESISTANCE | 4.12 |
| RESISTANCE | 4.07 |
| SUPPORT | 3.93 |
| SUPPORT | 3.88 |
| SUPPORT | 3.83 |
| SUPPORT | 3.75 |
ALT Forecast April 2024
| 4th UP Forecast | 9.61 |
| 3rd UP Forecast | 7.81 |
| 2nd UP Forecast | 6.7 |
| 1st UP Forecast | 5.59 |
| 1st DOWN Forecast | 2.41 |
| 2nd DOWN Forecast | 1.3 |
| 3rd DOWN Forecast | 0.19 |
| 4th DOWN Forecast | -1.61 |
ALT Weekly Forecast
| 4th UP Forecast | 5.68 |
| 3rd UP Forecast | 5.14 |
| 2nd UP Forecast | 4.81 |
| 1st UP Forecast | 4.47 |
| 1st DOWN Forecast | 3.53 |
| 2nd DOWN Forecast | 3.19 |
| 3rd DOWN Forecast | 2.86 |
| 4th DOWN Forecast | 2.32 |
ALT Forecast2024
| 4th UP Forecast | 41.9 |
| 3rd UP Forecast | 29.75 |
| 2nd UP Forecast | 22.23 |
| 1st UP Forecast | 14.72 |
| 1st DOWN Forecast | -6.72 |
| 2nd DOWN Forecast | -14.23 |
| 3rd DOWN Forecast | -21.75 |
| 4th DOWN Forecast | -33.9 |
Altimmune Inc ( NASDAQ USA Symbol : ALT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ALT Business Profile
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing intranasal vaccines, immune modulating therapies, and treatments for liver disease. The company develops AdCOVID, a single-dose intranasal vaccine that is in Phase I clinical trial to protect against COVID-19; T-COVID, an intranasal immune modulating therapeutic candidate, which is in Phase I/II clinical trial to evaluate the potential of T-COVID to prevent clinical worsening in patients with early COVID-19; NasoShield, an anthrax vaccine product candidate that is in a Phase 1b trial; and NasoVAX, a recombinant intranasal vaccine product candidate, which completed Phase IIa clinical trial for the treatment of seasonal and pandemic use. It also focuses on developing ALT-801, a novel peptide-based dual GLP-1/glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis that is in Phase I clinical trial; and HepTcell, an immunotherapeutic product candidate, which is in Phase II clinical trial for patients chronically infected with the hepatitis B virus. Altimmune, Inc. has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. The company is headquartered in Gaithersburg, Maryland. Address: 910 Clopper Road, Gaithersburg, MD, United States, 20878
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service